US$ 28.94
shortage of glp-1 receptor agonists for individualized treatment type 2 diabetes mellitus GLP-1 Agonists Market Report 2025-2033,
Description
qw, once weekly

Brain Res (2012) 1473:20413

KSL was supported by the Independent Research Fund Denmark (8045-00047B), NordForsk (id: 156298), and Centre for Childhood Health (id: 72 2024_F_008 and 2024_I_001)

doi: 10.1111/j.1464-5491.2009.02666.x [DOI] [PMC free article] [PubMed] [Google Scholar] 220

ALOX15 aggravates metabolic dysfunction-associated steatotic liver disease in mice with type 2 diabetes via activating the PPAR/CD36 axis

Side Effects Comparison Since both medications affect gut hormones and slow gastric emptying, they cause similar side effects
